Nerve Access, Inc.

$5B effective Alzheimer's therapeutic, FDA placed on expedited approval pathway, $3MM needed to file IND and conduct clinical Phase IIa.

  • Stage Product In Development
  • Industry Biotechnology
  • Location United States
  • Currency USD
  • Founded July 2008
  • Employees 6
  • Website nerveaccess.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free